Renal Involvement in Systemic Diseases: A 13-Year Retrospective Renal Biopsy Study in Sub-Saharan African Patients
- 1 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 2 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 3 Anatomic Pathology Department, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 4 Anatomic Pathology Department, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 5 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 6 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 7 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 8 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 9 Nephrology Department, Aristide Le Dantec Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 10 Nephrology Department, Aristide Le Dantec Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 11 Nephrology Department, Aristide Le Dantec Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
- 12 Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University of Dakar, Dakar, Senegal
Abstract
Background : Renal involvement is a frequent and potentially severe complication of systemic diseases, particularly immune-mediated disorders. Renal biopsy remains the gold standard for diagnosing, classifying, and guiding the management of renal lesions associated with these conditions. Data from Sub-Saharan Africa remain limited. Objectives : To describe the clinical indications and histopathological spectrum of renal involvement in systemic diseases based on renal biopsy findings over a 13-year period in a tertiary referral center in Sub-Saharan Africa. Methods : We conducted a single-center retrospective observational study from January 2011 to December 2023 in a university hospital pathology center in Senegal. All patients with a known or suspected systemic disease who underwent a renal biopsy and had histologically confirmed renal involvement were included. Sociodemographic data, biopsy indications, and histopathological findings were analyzed descriptively. Results : A total of 263 patients were included, representing 7.95% of all renal biopsies performed during the study period. The mean age was 39.1 ± 12.6 years, with a female predominance (72%). Renal biopsy indications were mainly related to systemic lupus erythematosus (SLE) (65.39%), dominated by proteinuria and renal failure. In 43.34% of cases, the diagnosis of the systemic disease was established based on renal biopsy findings. Histopathologically, membranous glomerulopathy and lupus nephritis were the most frequent lesions, with a predominance of proliferative forms, particularly class IV (22.05%) and class III (11.02%). Other lesions included membranoproliferative glomerulonephritis, crescentic glomerulonephritis, amyloidosis, tubulointerstitial nephritis, and thrombotic microangiopathy. SLE was the most common underlying systemic disease (80.60%), followed by cryoglobulinemia and amyloidosis among non-autoimmune conditions. Conclusion : Renal involvement in systemic diseases exhibits a wide clinical and histological spectrum, largely dominated by lupus nephritis. Given the nonspecific clinical presentations, renal biopsy is essential for accurate diagnosis, prognostic assessment, and therapeutic decision-making. These findings highlight the importance of improving access to renal biopsy and conducting prospective studies in Sub-Saharan Africa.
- Couser, W.G. (1999) Glomerulonephritis. The Lancet , 353, 1509-1515. https://doi.org/10.1016/s0140-6736(98)06195-9
- Kidney Disease: Improving Global Outcomes (KDIGO) (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International , 100, S1-S276.
- Almaani, S., Meara, A. and Rovin, B.H. (2017) Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology , 12, 825-835. https://doi.org/10.2215/cjn.05780616
- Weening, J.J., D’agati, V.D., Schwartz, M.M., Seshan, S.V., Alpers, C.E., Appel, G.B., et al . (2004) The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited. Kidney International , 65, 521-530. https://doi.org/10.1111/j.1523-1755.2004.00443.x
- Tektonidou, M.G., Dasgupta, A. and Ward, M.M. (2016) Risk of End‐Stage Renal Disease in Patients with Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta‐Analysis. Arthritis & Rheumatology , 68, 1432-1441. https://doi.org/10.1002/art.39594
- Jennette, J.C. and Falk, R.J. (1997) Small-Vessel Vasculitis. New England Journal of Medicine , 337, 1512-1523. https://doi.org/10.1056/nejm199711203372106
- Berden, A.E., Ferrario, F., Hagen, E.C., Jayne, D.R., Jennette, J.C., Joh, K., et al . (2010) Histopathologic Classification of Anca-Associated Glomerulonephritis. Journal of the American Society of Nephrology , 21, 1628-1636. https://doi.org/10.1681/asn.2010050477
- Ponticelli, C. and Moroni, G. (2010) Renal Manifestations of Systemic Sclerosis. Journal of Nephrology , 23, 148-154.
- Goules, A.V., Tatouli, I.P., Moutsopoulos, H.M. and Tzioufas, A.G. (2013) Clinically Significant Renal Involvement in Primary Sjögren’s Syndrome: Clinical Presentation and Outcome. Arthritis & Rheumatism , 65, 2945-2953. https://doi.org/10.1002/art.38100
- Pozzi, C. and D’Amico, M. (2011) Renal Manifestations of Plasma Cell Dyscrasias. Journal of the American Society of Nephrology , 22, 1300-1308.
- Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., et al . (2003) Morbidity and Mortality in Systemic Lupus Erythematosus during a 10-Year Period: A Comparison of Early and late Manifestations in a Cohort of 1000 Patients. Medicine (Baltimore). Medicine , 82, 299-308. https://doi.org/10.1097/01.md.0000091181.93122.55
- Lachmann, H.J., Goodman, H.J.B., Gilbertson, J.A., Gallimore, J.R., Sabin, C.A., Gillmore, J.D., et al . (2007) Natural History and Outcome in Systemic AA Amyloidosis. New England Journal of Medicine , 356, 2361-2371. https://doi.org/10.1056/nejmoa070265